CYP19A1 and polycystic ovary syndrome: Furthermore, this is the first report to show that OX1Ra + OX2Ra treatment reversed the expression of Cyp19a1 and testosterone levels in the PCOS model of rats, implying that orexins differentially affect steroidogenesis and contribute to the pathogenesis of PCOS.